Innate Pharma (IPHA) EPS (Basic) (2019 - 2025)
Innate Pharma's (IPHA) quarterly EPS (Basic) came in at -$0.28 in Q2 2025, up 15.72% YoY from -$0.24 in Q2 2024, and up 57.39% on a QoQ basis from -$0.65 in Q4 2024.
Innate Pharma (IPHA) EPS (Basic) (2019 - 2025) Analysis & Trends
Innate Pharma (IPHA) has 7 years of EPS (Basic) data on file, last reported at -$0.28 in Q2 2025.
- Quarterly EPS (Basic) rose 15.72% year-over-year to -$0.28 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was -$1.16 (down 7.75% YoY) and the FY2025 annual result came in at -$0.28, down 342.12% from the prior year.
- EPS (Basic) advanced to -$0.28 in Q2 2025, from -$0.65 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $1.55 in Q4 2021 to a low of -$0.65 in Q4 2024.
- A 5-year average of $0.06 and a median of -$0.1 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) surged 888.43% — and 2024, when it sank 4382.21%.
- Tracing IPHA's EPS (Basic) over 5 years: stood at $1.55 in 2021, then tumbled by 55.1% to $0.69 in 2022, then tumbled by 114.59% to -$0.1 in 2023, then sank by 544.26% to -$0.65 in 2024, then jumped by 57.39% to -$0.28 in 2025.
- The last three EPS (Basic) figures came in at -$0.28 (Q2 2025), -$0.65 (Q4 2024), and -$0.33 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 0.18 |
| 10 | Innate Pharma | 200.24 Mn | 200.24 Mn | - | -0.64 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -0.28 |
| Dec 31, 2024 | -0.65 |
| Jun 30, 2024 | -0.33 |
| Dec 31, 2023 | -0.10 |
| Jun 30, 2023 | 0.01 |
| Dec 31, 2022 | 0.69 |
| Jun 30, 2022 | 0.00 |
| Dec 31, 2021 | 1.55 |
| Jun 30, 2021 | -0.36 |
| Dec 31, 2020 | -0.95 |
| Jun 30, 2020 | -0.14 |
| Dec 31, 2019 | -0.34 |